Entacapone (Comtan) News, Updated Regularly

Finnish Orion files U.S. lawsuit to protect key drug - Reuters
November 12, 2008, 1:09 pm

HELSINKI, Nov 12 (Reuters) - Finnish drug firm Orion (ORNBV.HE: Quote , Profile , Research , Stock Buzz ) said on Wednesday it has filed a patent infringement lawsuit in the United States to protect its key drug Comtan, used for treatment of ...

Orion in patent row with Sun - Business Standard
November 14, 2008, 8:13 am

Orion had filed a similar suit against Wockhardt, another Indian company that sought regulatory approval for marketing the low-cost version of Comtan in the world?s largest drug market. Comtan contains entacapone, a product developed by Orion and ...

FDA Approvals: Vimpat and Stalevo CME - Medscape News
November 4, 2008, 3:56 pm

Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s) ? for physicians; Family Physicians - up to 0.25 AAFP Prescribed credit(s) for physicians To participate in this internet activity: (1) review the target audience, learning objectives, and ...

Two New Dosage Strengths Of Stalevo(R) Approved In The U.S. Provide ... - Medical News Today
October 27, 2008, 5:56 pm

Novartis Pharmaceuticals Corporation today announced the launch of two new FDA-approved dosage strengths of Stalevo(R) (carbidopa, levodopa and entacapone), which is indicated for certain people with Parkinson's disease who experience end-of-dose ...

Wockhardt challenges US patent of Parkinson's medicine - Business Standard
November 4, 2008, 8:25 am

Wockhardt has filed an abbreviated new drug-marketing application(ANDA) with the US Food and Drug Administration (FDA), seeking authorisation to produce and market a generic version of Stalevo in 12.5, 200 and 50 mg strengths, said Orion Corporation ...

FDA Approvals Index - Medscape News
November 13, 2008, 6:30 pm

FDA Approves Toviaz for Overactive Bladder By relaxing the bladder muscle, fesoterodine fumarate (Toviaz) reduces urinary frequency, the urge to urinate, and sudden urinary incontinence associated with OAB. News, November 2008 FDA Approvals: Vimpat ...

Parkinson's Disease Market Upgrade Following Evidence of Disease ... - PR Inside
October 16, 2008, 2:41 pm

www.researchandmarkets.com - Research and Markets ( www.researchandmarkets.com/research/c84a4e/forecast_insight ) has announced the addition of the "Forecast Insight: Parkinson's Disease - Market Upgrade following Evidence of Disease Slowing with ...

Wockhardt challenges US patent of Parkinson's drug - MSN India
November 3, 2008, 10:46 pm

Mumbai: Drug major Wockhardt has challenged the US patent of Stalevo, a new generation combination drug for the treatment of Parkinson's disease, originated by Finland-based Orion Corporation and marketed by Novartis. Wockhardt has filed an ...

Orion Corporation (FI) - Orion Group Interim Report 1-9/2008 - Phramalive.com
October 28, 2008, 5:30 am

ESPOO, Finland, Oct. 28, 2008- Orion's net sales in January-September 2008 stood at EUR 530.1 million (1-9/2007: EUR 509.6 million), up by 4.0% on the comparative period of January-September 2007. Operating profit was EUR 152.2 (153.4) million ...

Are you looking for additional Comtan (Entacapone) news? Try our new "Entacapone News Focus" area.

Are you looking for additional Comtan (Entacapone) information? Try our new "Entacapone Related Blog Entries" area.

Off-site Entacapone (Comtan) Links, User Submitted

The following links have been collected through user bookmark submission in the Entacapone_Comtan category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Off-site Entacapone Research Links

If you still need additional information on Entacapone then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.